Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: Outcome and comparison of light sources

Photodermatology Photoimmunology and Photomedicine

Volumn 19, Issue 3, 2003, Pages 134-141

  Clark, C ^a   Bryden, A ^a   Dawe, R ^a   Moseley, H ^a   Ferguson, J ^a   Ibbotson, Sally H ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

5 aminolaevulinic acid; Actinic keratosis; Bowen's disease; Photodynamic therapy; Superficial basal cell carcinoma

Indexed keywords

AMINOLEVULINIC ACID; FLUOROURACIL; HALIDE; HALOGEN; LIDOCAINE; TETRACAINE; XENON;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; BURNING SENSATION; CANCER RECURRENCE; CONTROLLED STUDY; DIODE LASER; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG PENETRATION; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; HISTOLOGY; HUMAN; INTERMETHOD COMPARISON; IRRADIATION; LIGHT; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; PAIN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN CANCER; SKIN EDEMA; SKIN PIGMENTATION; SKIN SCAR; TREATMENT OUTCOME; URTICARIA;

ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; BOWEN'S DISEASE; CARCINOMA, BASAL CELL; ENGLAND; FEMALE; HUMANS; KERATOSIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0037703819     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0781.2003.00024.x     Document Type: Article

References (37)

1. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX Basic principles and present clinical experience. J Photochem Photobiol B Biol 1990; 6: 143-148.
2. Wolf P, Rieger E, Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas. J Am Acad Dermatol 1993; 28: 17-21.
3. Cairnduff F, Stringer MR, Hudson EJ, Ash DV, Brown SB. Superficial photodynamic therapy with optical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. Br J Cancer 1994; 69: 605-608.
4. Svanberg K, Andersson T, Killander D et al. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical d-aminolevulinic acid sensitization and laser irradiation. Br J Dermatol 1994; 130: 743-751.
5. Calzavara-Pinton PG. Repetitive photodynamic therapy with topical delta-aminolevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J Photochem Photobiol B Biol 1995; 29: 53-57.
6. Peng Q, Warloe T, Berg K et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 1997; 79: 2282-2308.
7. Fritsch C, Goerz G, Ruzicka T. Photodynamic therapy in dermatology. Arch Dermatol 1998; 134: 207-214.
8. Kalka K, Merk H, Mukhtar H. Photodynamic therapy in dermatology. J Am Acad Dermatol 2000; 42: 389-413.
9. Jeffes EW, McCullough JL, Weinstein GD et al. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid A pilot dose-ranging study. Arch Dermatol 1997; 133: 727-732.
10. Morton CA, Whitehurst C, Moseley H, McColl JH, Moore JV, MacKie RM. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol 1996; 135: 766-777.
11. Salim A, Morton CA. Comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol 2000; 143: S57-114.
12. Wang I, Bendsoe N, Klinteberg CA et al. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 2001; 144: 832-840.
13. Kurwa HA, Yong-Gee SA, Seed PT, Markey AC, Barlow RJ. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J Am Acad Dermatol 1999; 41: 414-418.
14. Stender IM, Na R, Fogh H, Gluud C, Wulf HC. Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial. Lancet 2000; 355: 963-966.
15. Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer. Br J Dermatol 2002; 146: 178-188.
16. Lui H, Anderson RR. Photodynamic therapy in dermatology: recent developments. Dermatol Clin 1993; 11: 1-13.
17. Brancaleon L, Moseley H. Lasers and non-laser light sources for photodynamic therapy. Laser Med Sci 2002; 17: 173-186.
18. Jeffes EW, McCullough JL, Weinstein GD, Kaplan R, Glazer SD, Taylor JR. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. J Am Acad Dermatol 2001; 45: 96-104.
19. Soler AM, Angell-Petersen E, Warloe T et al. Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: a comparison of two light sources. Photochem Photobiol 2000; 71: 724 729.
20. Szeimies RM, Hein R, Baumler W, Heine A, Landthaler M. A possible new incoherent lamp for photodynamic treatment of superficial skin lesions. Acta Derm Venereol (Stockh) 1994; 74: 117-119.
21. Cox NH, Eady DJ, Morton CA. Guidelines for the management of Bowen's disease. Br J Dermatol 1999; 141: 633-641.
22. Albright SD. Treatment of skin cancer using multiple modalities. J Am Acad Dermatol 1982; 7: 143-171.
23. Sweet RD. The management of basal cell carcinoma by curettage. Br J Dermatol 1963; 75: 137-148.
24. Bell HK, Rhodes LE. Bowen's disease: a retrospective review of clinical management. Clin Exp Dermatol 1999; 24: 336-337.
25. Telfer NR, Colver GB, Bowers PW. Guidelines for the management of basal cell carcinoma. Br J Dermatol 1999; 141: 415-423.
26. Cox NH, Dyson P. Wound healing on the lower leg after radiotherapy or cryotherapy of Bowen's disease and other malignant skin lesions. Br J Dermatol 1995; 133: 60-65.
27. Morton CA, Brown SB, Collins S et al. Guidelines for topical photodynamic therapy: a report of a Workshop of the British Photodermatology Group. Br J Dermatol 2002; 146: 552-567.
28. Morton CA, MacKie RM, Whitehurst C, Moore JV, McColl JH. Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response. Arch Dermatol 1998; 134: 248-249.
29. Varma S, Wilson H, Kurwa HA et al. Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source. Br J Dermatol 2001; 144: 567-574.
30. Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989; 15: 315-328.
31. Stables GI, Stringer MR, Robinson DJ, Ash DV. Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy. Br J Dermatol 1997; 136: 957-960.
32. Morton CA, Whitehurst C, McColl JH, Moore JV, MacKie RM. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. Arch Dermatol 2001; 137: 319-324.
33. Gomer CJ, Rucker N, Murphree AL. Differential cell photosensitivity following porphyrin photodynamic therapy. Cancer Res 1988; 48: 4539-4542.
34. Henta T, Itoh Y, Kobayashi M, Ninomiya Y, Ishibashi A. Photodynamic therapy for inoperable vulval Paget's disease using δ-aminolaevulinic acid: successful management of a large skin lesion. Br J Dermatol 1999; 141: 347-349.
35. Moseley H. Total effective fluence: a useful concept in photodynamic therapy. Laser Med Sci 1995; 10: 165-168.
36. Markham T, Collins P. Low light-dose, low dose-rate topical 5-aminolaevulinic acid photodynamic therapy is effective for superficial skin cancers. Br J Dermatol 2000; 143: S57-114.
37. Langmack K, Mehta R, Twyman P, Norris P. Topical photodynamic therapy at low fluence rates - theory and practice. J Photochem Photobiol B 2001; 60: 37-43.